Marshall University receives $3.3 million grant to examine genetic mechanisms behind fentanyl addiction

FHS
July 20, 2024
1:36 am

Marshall University was awarded a $3.3 million grant (#R01DA057931) from the National Institute on Drug Abuse (NIDA) to examine the genetic mechanisms that underlie fentanyl addiction.

AbbVie and Umoja to develop new CAR-T therapies for cancer

Share this article Under the initial deal, AbbVie will obtain a sole licensing option for CD19-directed in-situ generated CAR-T cell therapy candidates of Umoja. Credit:

January 5, 2024

What the mifepristone case means, GLP-1 skepticism, & Chinese biotech

Who gets to sue the FDA? Is pharma caught in a trade war? And what does “AF” stand for? We cover all that and more

March 28, 2024

Sugary Drinks Tied to Higher Liver Cancer Risk in Women

Regularly drinking sugar-sweetened beverages was associated with a significantly increased incidence of liver cancer and death from chronic liver disease, according to a prospective cohort

August 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.